-
Price Momentum
CODX is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of CODX shares has increased $0.10 since the market last closed. This is a 7.09% rise.
-
Last closed at $1.51.
The stock has since dropped $0.04 in pre-market trading.
Key terms
About CODX
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
-
Market cap: $7.97M
A market capitalization up to $300 million places CODX in the micro-capitalization category.
Key terms
Smart score
Latest CODX news
CODX Financials
-
Total revenue: $418.20K (1Y), $145.95K (Q1)
Total Revenue decreased 45.69% since last year and increased 144.73% since last quarter.
-
Net income: -$46.90M (1Y), -$9.14M (Q1)
Net Income decreased 24.59% since last year and increased 64.5% since last quarter.
-
Earnings per share: -$35.25 (1Y), -$4.06 (Q1)
EPS increased 5.29% since last year and increased 66.99% since last quarter.
Key terms
CODX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CODX Competitors
-
How competitors are chosen
CODX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $7.97M
A market capitalization up to $300 million places CODX in the micro-capitalization category.






